The Franklin, Tenn.-based hospital chain’s stock price traded as high as $1.96 on Aug. 23 after closing Aug. 22 at $1.95 per share. In the last year, CHS shares have traded between $1.81 and $5.35.
CHS, which operates 105 hospitals in 18 states, saw its net loss swell in the second quarter of 2019. The company ended the second quarter of this year with a net loss of $167 million on revenues of $3.3 billion. In the second quarter of 2018, CHS recorded a net loss of $110 million on revenue of $3.6 billion.
More articles on healthcare finance:
State-by-state breakdown of 113 rural hospital closures
Advocate Aurora Health’s net income more than doubles in Q2
6 latest hospital credit rating downgrades
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
